How can shareholders protect a possibly favorable T3 outcome?

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

ease2002

Rank: Treasurer [?]

Points: 289 [?]

Votes: 21 Score: 2.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

How can shareholders protect a possibly favorable T3 outcome?

posted on Jul 21, 2011 10:36AM

I'm not sure shareholders can wait for a T3 outcome. Do shareholders need to unite and submit an official request to the SEC to protect PTSC's MMP share in the T3 litigation if there is/was suspect management?

Too many questions about the BOD's intent to leave our negotiation up to them. I would prefer a whole new slate of management, and the only way these folks will leave is if they are forced out by the SEC if there was any wrongdoing.

I do not expect T3 resolution until May or June of 2012. Can shareholders play the wait and see game again?

A certified letter from a law firm to the SEC enumerate all of the issues will show that we at least tried. Personally, I'm not sure we can wait until May or June of 2012.